ATRAPOS THERAPEUTICS
Atrapos Therapeutics develops immunomodulatory therapeutics for the management of diseases originating from overactive immune responses. Atrapos targets STAT6 protein, a key nexus in the dysregulation of immune cell-driven allergic diseases. Other targets upstream of STAT6 that contribute to this dysregulation are currently targeted by FDA-approved therapeutics for the treatment of some of these allergic diseases.
ATRAPOS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Houston, Texas, United States
Country:
United States
Status:
Active
Similar Organizations
Atlas Regeneration
Atlas Regeneration is developing pioneering bioinformatics solutions for regenerative medicine.
Medallion Therapeutics
Medallion Therapeutics specializes in drug and biologics delivery solutions.